ID

38808

Descrizione

The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE Study; ODM derived from: https://clinicaltrials.gov/show/NCT01966978

collegamento

https://clinicaltrials.gov/show/NCT01966978

Keywords

versioni (1)
  1. 05/11/19 05/11/19 -
Titolare del copyright

See clinicaltrials.gov

Caricato su

5 novembre 2019

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Diabetes Mellitus, Type 2 NCT01966978

Inglese

Eligibility Diabetes Mellitus, Type 2 NCT01966978

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. clinical diagnosis of type 2 diabetes with confirmed hba1c level >10% at time of enrollment, regardless of prior or current treatment regimens, or time since diagnosis.
Descrizione

Diabetes Mellitus, Non-Insulin-Dependent | Hemoglobin A1c measurement

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2]
C0474680
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. age <18 as the feasibility and safety of this treatment regimen should be first established in the adult population; if successful, a subsequent pediatric study will be proposed;
Descrizione

Age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
2. type 1 diabetes as purposefully withholding meal-time insulin is contraindicated;
Descrizione

Diabetes Mellitus, Insulin-Dependent | Medical contraindication Mealtime Insulin

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0011854
UMLS CUI [2,1]
C1301624
UMLS CUI [2,2]
C0587119
UMLS CUI [2,3]
C0021641
3. clinical state requiring inpatient admission/treatment;
Descrizione

Clinical state Requirement Hospital admission | Clinical state Requirement Inpatient treatment

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0457936
UMLS CUI [1,2]
C1514873
UMLS CUI [1,3]
C0184666
UMLS CUI [2,1]
C0457936
UMLS CUI [2,2]
C1514873
UMLS CUI [2,3]
C0019993
4. contraindication or strong cautions to any of the study medications:
Descrizione

Medical contraindication Investigational New Drugs

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0013230
1. creatinine above 1.4 mg/dl for women and 1.5 mg/dl for men (per metformin label)
Descrizione

Creatinine measurement, serum | Gender

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0201976
UMLS CUI [2]
C0079399
2. history of lactic acidosis (per metformin label)
Descrizione

Acidosis, Lactic

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001125
3. advanced hepatic or cardiac disease (per metformin label)
Descrizione

Liver disease Advanced | Heart Disease Advanced

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0023895
UMLS CUI [1,2]
C0205179
UMLS CUI [2,1]
C0018799
UMLS CUI [2,2]
C0205179
4. age >80 years (per metformin label)
Descrizione

Age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
5. chronic alcohol use (>14 drinks/week)
Descrizione

Alcohol consumption chronic | Drinks per week

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0001948
UMLS CUI [1,2]
C0205191
UMLS CUI [2,1]
C0001967
UMLS CUI [2,2]
C0332174
6. history of pancreatitis (per liraglutide label)
Descrizione

Pancreatitis

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0030305
7. personal or family history of medullary thyroid cancer or men syndrome (per liraglutide label)
Descrizione

Medullary carcinoma of thyroid | Familial medullary thyroid carcinoma | Multiple Endocrine Neoplasia

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0238462
UMLS CUI [2]
C1833921
UMLS CUI [3]
C0027662
8. pregnancy and lactation (per liraglutide label)
Descrizione

Pregnancy | Breast Feeding

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
5. any serious or unstable medical condition as it would interfere with treatment assignment as well as outcome measurement;
Descrizione

Medical condition Serious Interferes with Therapeutic procedure | Medical condition Unstable Interferes with Therapeutic procedure | Medical condition Serious Interferes with Outcome Measurement | Medical condition Unstable Interferes with Outcome Measurement

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C0205404
UMLS CUI [1,3]
C0521102
UMLS CUI [1,4]
C0087111
UMLS CUI [2,1]
C3843040
UMLS CUI [2,2]
C0443343
UMLS CUI [2,3]
C0521102
UMLS CUI [2,4]
C0087111
UMLS CUI [3,1]
C3843040
UMLS CUI [3,2]
C0205404
UMLS CUI [3,3]
C0521102
UMLS CUI [3,4]
C2985619
UMLS CUI [4,1]
C3843040
UMLS CUI [4,2]
C0443343
UMLS CUI [4,3]
C0521102
UMLS CUI [4,4]
C2985619
6. any scheduled elective procedures/surgeries;
Descrizione

Elective procedure Scheduled | Elective Surgical Procedures Scheduled

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0747973
UMLS CUI [1,2]
C0205539
UMLS CUI [2,1]
C0206058
UMLS CUI [2,2]
C0205539
7. active infections, including osteomyelitis;
Descrizione

Communicable Diseases | Osteomyelitis

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0009450
UMLS CUI [2]
C0029443
8. not willing to participate, unable to keep projected appointments, unwillingness to receive injectable treatment; unwillingness to perform 7-point glucose profiles over 2 consecutive days the weeks prior to randomization (visit 1)and the week prior to visit 6
Descrizione

Participation Unwilling | Protocol Compliance Unwilling

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0679823
UMLS CUI [1,2]
C0558080
UMLS CUI [2,1]
C0525058
UMLS CUI [2,2]
C0558080
9. non english speaking.
Descrizione

Lacking Able to speak English Language

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0332268
UMLS CUI [1,2]
C0564215
UMLS CUI [1,3]
C0376245
Ritorna all'inizio della pagina

Similar models

Eligibility Diabetes Mellitus, Type 2 NCT01966978

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent | Hemoglobin A1c measurement
Item
1. clinical diagnosis of type 2 diabetes with confirmed hba1c level >10% at time of enrollment, regardless of prior or current treatment regimens, or time since diagnosis.
boolean
C0011860 (UMLS CUI [1])
C0474680 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Age
Item
1. age <18 as the feasibility and safety of this treatment regimen should be first established in the adult population; if successful, a subsequent pediatric study will be proposed;
boolean
C0001779 (UMLS CUI [1])
Diabetes Mellitus, Insulin-Dependent | Medical contraindication Mealtime Insulin
Item
2. type 1 diabetes as purposefully withholding meal-time insulin is contraindicated;
boolean
C0011854 (UMLS CUI [1])
C1301624 (UMLS CUI [2,1])
C0587119 (UMLS CUI [2,2])
C0021641 (UMLS CUI [2,3])
Clinical state Requirement Hospital admission | Clinical state Requirement Inpatient treatment
Item
3. clinical state requiring inpatient admission/treatment;
boolean
C0457936 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C0184666 (UMLS CUI [1,3])
C0457936 (UMLS CUI [2,1])
C1514873 (UMLS CUI [2,2])
C0019993 (UMLS CUI [2,3])
Medical contraindication Investigational New Drugs
Item
4. contraindication or strong cautions to any of the study medications:
boolean
C1301624 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
Creatinine measurement, serum | Gender
Item
1. creatinine above 1.4 mg/dl for women and 1.5 mg/dl for men (per metformin label)
boolean
C0201976 (UMLS CUI [1])
C0079399 (UMLS CUI [2])
Acidosis, Lactic
Item
2. history of lactic acidosis (per metformin label)
boolean
C0001125 (UMLS CUI [1])
Liver disease Advanced | Heart Disease Advanced
Item
3. advanced hepatic or cardiac disease (per metformin label)
boolean
C0023895 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C0018799 (UMLS CUI [2,1])
C0205179 (UMLS CUI [2,2])
Age
Item
4. age >80 years (per metformin label)
boolean
C0001779 (UMLS CUI [1])
Alcohol consumption chronic | Drinks per week
Item
5. chronic alcohol use (>14 drinks/week)
boolean
C0001948 (UMLS CUI [1,1])
C0205191 (UMLS CUI [1,2])
C0001967 (UMLS CUI [2,1])
C0332174 (UMLS CUI [2,2])
Pancreatitis
Item
6. history of pancreatitis (per liraglutide label)
boolean
C0030305 (UMLS CUI [1])
Medullary carcinoma of thyroid | Familial medullary thyroid carcinoma | Multiple Endocrine Neoplasia
Item
7. personal or family history of medullary thyroid cancer or men syndrome (per liraglutide label)
boolean
C0238462 (UMLS CUI [1])
C1833921 (UMLS CUI [2])
C0027662 (UMLS CUI [3])
Pregnancy | Breast Feeding
Item
8. pregnancy and lactation (per liraglutide label)
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Medical condition Serious Interferes with Therapeutic procedure | Medical condition Unstable Interferes with Therapeutic procedure | Medical condition Serious Interferes with Outcome Measurement | Medical condition Unstable Interferes with Outcome Measurement
Item
5. any serious or unstable medical condition as it would interfere with treatment assignment as well as outcome measurement;
boolean
C3843040 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0521102 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,4])
C3843040 (UMLS CUI [2,1])
C0443343 (UMLS CUI [2,2])
C0521102 (UMLS CUI [2,3])
C0087111 (UMLS CUI [2,4])
C3843040 (UMLS CUI [3,1])
C0205404 (UMLS CUI [3,2])
C0521102 (UMLS CUI [3,3])
C2985619 (UMLS CUI [3,4])
C3843040 (UMLS CUI [4,1])
C0443343 (UMLS CUI [4,2])
C0521102 (UMLS CUI [4,3])
C2985619 (UMLS CUI [4,4])
Elective procedure Scheduled | Elective Surgical Procedures Scheduled
Item
6. any scheduled elective procedures/surgeries;
boolean
C0747973 (UMLS CUI [1,1])
C0205539 (UMLS CUI [1,2])
C0206058 (UMLS CUI [2,1])
C0205539 (UMLS CUI [2,2])
Communicable Diseases | Osteomyelitis
Item
7. active infections, including osteomyelitis;
boolean
C0009450 (UMLS CUI [1])
C0029443 (UMLS CUI [2])
Participation Unwilling | Protocol Compliance Unwilling
Item
8. not willing to participate, unable to keep projected appointments, unwillingness to receive injectable treatment; unwillingness to perform 7-point glucose profiles over 2 consecutive days the weeks prior to randomization (visit 1)and the week prior to visit 6
boolean
C0679823 (UMLS CUI [1,1])
C0558080 (UMLS CUI [1,2])
C0525058 (UMLS CUI [2,1])
C0558080 (UMLS CUI [2,2])
Lacking Able to speak English Language
Item
9. non english speaking.
boolean
C0332268 (UMLS CUI [1,1])
C0564215 (UMLS CUI [1,2])
C0376245 (UMLS CUI [1,3])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial